NCT07025226 2026-01-26
Senolytics
Mayo Clinic
Phase EARLY_PHASE1 Recruiting
Clinical Trials
13 trialsNCT04733534 2026-01-20
An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer
St. Jude Children's Research Hospital
Phase 2 Active not recruiting
NCT06615752 2025-11-12
Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients
Charles Drew University of Medicine and Science
Phase 1/2 Recruiting
NCT03476330 2025-04-27
Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia
Children's Hospital Medical Center, Cincinnati
Phase 2 Active not recruiting
NCT05724329 2024-09-19
Neoadjuvant Tislelizumab in Combination With Dasatinib and Quercetin in Resectable HNSCC (COIS-01)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Active not recruiting
NCT06355037 2024-07-08
Dasatinib Combined With Quercetin to Reverse Chemo Resistance in Triple Negative Breast Cancer
Fudan University
Phase 2 Recruiting
NCT06209229 2024-01-17
RNE
MIPO Clinic
Phase 1 Completed
NCT05680662 2023-01-11
The Study of Quadruple Therapy Quercetin, Zinc, Metformin, and EGCG as Adjuvant Therapy for Early, Metastatic Breast Cancer and Triple-negative Breast Cancer, a Novel Mechanism
Ministry of Health, Saudi Arabia
Phase EARLY_PHASE1 Unknown
NCT05456022 2022-07-13
Therapeutic Efficacy of Quercetin Versus Its Encapsulated Nanoparticle on Tongue Squamous Cell Carcinoma Cell Line
Cairo University
Phase 2 Unknown
NCT02989129 2018-04-18
Trial of Quercetin in the Treatment and Prevention of Chemotherapy-induced Neuropathic Pain in Cancer Patients
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Withdrawn
NCT01732393 2012-12-05
Effect of Quercetin in Prevention and Treatment of Oral Mucositis
Mashhad University of Medical Sciences
Phase 1/2 Completed
NCT00003365 2011-01-27
Sulindac and Plant Compounds in Preventing Colon Cancer
Rutgers, The State University of New Jersey
Phase NA Terminated
NCT00455416 2008-05-21
KLYMF
Oslo University Hospital
Phase 2 Unknown